These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2446063)

  • 1. Pathophysiological relevance of serotonin.
    van Zwieten PA
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S19-25. PubMed ID: 2446063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiological and pharmacotherapeutic aspects of serotonin and serotonergic drugs.
    van Zwieten PA; Blauw GJ; van Brummelen P
    Clin Physiol Biochem; 1990; 8 Suppl 3():1-18. PubMed ID: 2132170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonergic type-2 (5-HT2) antagonists: a novel class of cardiovascular drugs.
    Robertson JI
    J Cardiovasc Pharmacol; 1991; 17 Suppl 5():S48-53. PubMed ID: 1717773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serotoninergic receptors and cardiovascular diseases].
    Hong E; Castillo C; Flores E; Mercedes F
    Gac Med Mex; 1994; 130(3):131-3. PubMed ID: 7657075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin and the vascular system. Role in health and disease, and implications for therapy.
    Houston DS; Vanhoutte PM
    Drugs; 1986 Feb; 31(2):149-63. PubMed ID: 3512233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin and preactivated platelets in essential hypertension.
    Bühler FR; Amstein R; Fetkovska N
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S32-4. PubMed ID: 2446066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of serotonin in cardiovascular diseases and their treatment.
    van Zwieten PA; Blauw GJ; van Brummelen P
    Cardiovasc Drugs Ther; 1990 Dec; 4(6):1443-7. PubMed ID: 2081137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin 5-HT2 receptors and brain circulation.
    Wiernsperger N
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S20-4. PubMed ID: 1369712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between S2-serotonergic and alpha 1-adrenergic receptor activities at vascular sites.
    Van Nueten JM; Janssens WJ; Xhonneux R; Janssen PA
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S10-5. PubMed ID: 2459506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age and the platelet serotonin vasoconstrictor axis in essential hypertension.
    Amstein R; Fetkovska N; Lüscher TF; Kiowski W; Bühler FR
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S35-40. PubMed ID: 2459512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of serotonin.
    Vanhoutte PM
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S8-11. PubMed ID: 2446079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serotonin--blood platelets, vessels].
    Buczko W
    Acta Haematol Pol; 1994; 25(2 Suppl 2):61-5. PubMed ID: 7998476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].
    Moulignier A
    Rev Neurol (Paris); 1994; 150(1):3-15. PubMed ID: 7801037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin, 5-HT2 receptors, and their blockade by naftidrofuryl: a targeted therapy of vascular diseases.
    Wiernsperger NF
    J Cardiovasc Pharmacol; 1994; 23 Suppl 3():S37-43. PubMed ID: 7517475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent insights into the pathogenesis of abdominal symptoms in functional bowel disorders].
    Cervio E; Rondanelli M; Balestra B; Dellabianca A; Agazzi A; Giacosa A; Tonini M
    Recenti Prog Med; 2007 Feb; 98(2):69-73. PubMed ID: 17439064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-hydroxytryptamine and vascular disease.
    Vanhoutte PM
    Fed Proc; 1983 Feb; 42(2):233-7. PubMed ID: 6822294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular risk stratification. Systolic, diastolic or pulse pressure?].
    Pede S; Lombardo M
    Ital Heart J Suppl; 2001 Apr; 2(4):356-8. PubMed ID: 19397006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive peptides in cardiovascular (patho)physiology.
    Callera G; Tostes R; Savoia C; Muscara MN; Touyz RM
    Expert Rev Cardiovasc Ther; 2007 May; 5(3):531-52. PubMed ID: 17489676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin and the blood-vessel wall.
    Vanhoutte PM
    J Hypertens Suppl; 1986 Dec; 4(5):S112-5. PubMed ID: 3553471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of serotonin in intestinal luminal sensing and secretion.
    Hansen MB; Witte AB
    Acta Physiol (Oxf); 2008 Aug; 193(4):311-23. PubMed ID: 18462271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.